The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4%

Ads

You May Also Like

Cara Therapeutics to Present Data at Kidney Week 2017

STAMFORD, Conn., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology ...

Cempra Prices Public Offering of Common Stock

CHAPEL HILL, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

Aduro Biotech Announces Fourth Quarter and Full Year 2015 Financial Results

BERKELEY, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported ...